Category: Finance
-
Genomics-Blockchain Company Launches, Raises $4.3 Million
A new enterprise that promises to collect and protect a person’s genomic data with blockchain technology is starting up with the help of a genomics legend and $4.3 million in seed financing.
-
M.D. Anderson, Spin-Off Company Gain $50M from Texas Agency
M.D. Anderson Cancer Center and a spin-off enterprise formed earlier this month are receiving nearly $50 million in grants from Texas’s state cancer prevention and research agency.
-
Biotechs Collaborate on More Precise Gene, Cell Cancer Therapies
Two biotechnology enterprises developing cancer treatments are pooling their efforts to develop therapies aimed at more specific targets across a range of solid tumor types.
-
Fully Biodegradable Plastic Straws in Testing
A university research center and biodegradable plastics company are testing a new type of drink straw that degrades completely after use in normal soil and water conditions.
-
Genomic Sequencing for Newborns Studied in Clinical Trial
A group of newborn infants with genetic disorders that went undetected in standard testing will receive genomic sequencing in a clinical study of its safety and feasibility.
-
Start-Up to Tackle Neurodegenerative Diseases, Raises $31 Million
A new company is forming to develop treatments that protect against destruction of brain cells in Alzheimer’s disease and comparable nerve damage from chemotherapy.
-
Cancer Drug Delivery Through Milk Particles Under Study
A new research project is investigating components in raw cow’s milk that could make it possible to give chemotherapy for cancer as oral drugs rather than infusions.
-
Start-Up Developing Regenerative Liver Disease Treatments
A new enterprise founded by scientists, is underway developing treatments for advanced liver disorders that combine new drugs with cell and gene therapies to restore or replace liver functions.
-
Biotechs Partner on Antibody, T-Cell Cancer Therapies in $100M Deal
Two biotechnology companies with complementary technologies plan to create treatments for cancer that harness and modify cells from the immune system delivered with benign viruses.
-
Infographic – Harvard or Stanford? Venture Capitalists Revealed.
Our reporting on venture capital, much like other business media, tells about the companies investing in early-stage enterprises, but what about the people in the industry?